Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age

Vaccine

Volumn 13, Issue 11, 1995, Pages 973-977

  Aristegui J ^a,b   Muniz J ^a,b   Legorburu, A Pérez ^a,b   Imaz, M ^a,b   Arrate, J P ^a,b   Suarez M D ^a,b   Goiri, M D ^a,b  

^a HOSPITAL DE BASURTO   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Diphtheria; hepatitis B vaccine; immunisation reactogenicity; pertussis; simultaneous administration; tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG EFFICACY; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; NEWBORN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; TETANUS; VACCINATION;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG INTERACTIONS; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; POLIOVIRUS VACCINE, ORAL;

EID: 0029116614     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00040-8     Document Type: Article

References (26)

1. Immunoprophylaxis of neonates against hepatitis B
2. Perinatal transmission of Hepatitis B virus in high incidence countries
3. Hepatitis B: evolving epidemiology and implications for control
4. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)
5. Committee on Infectious Diseases. Universal hepatitis B immunization
6. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy
7. Simultaneous administration of Diphtheria-Tetanus-Pertussis-Polio and Hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis and hepatitis B surface antigen
8. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B antigen-positive mothers
9. A pilot model of vaccination against hepatitis-B virus suitable for mass vaccination campaigns in hyperendemic areas
10. Vaccination against hepatitis B: comparison of three different vaccination schedules
11. Effect of timing of hepatitis B vaccine dose on response to vaccine in Yucpa Indians
12. Control of Hepatitis B: to be or not to be?
13. Hepatitis B revaccination of neonates with inadequate response after primovaccination
14. Simultaneous administration of Measles-Mumps-Rubella vaccine with booster doses of Diphtheria-Tetanus-Pertussis and Poliovirus vaccines
15. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months versus 3, 5 and 9 months of age
16. The case for routine hepatitis B immunization in infancy for populations at increase risk
17. Simultaneous administration of hepatitis B and diphtheria/tetanus/polio vaccines
18. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
19. Diphtheria-Pertussis-Tetanus vaccine: reactogenicity of commercial products
20. Nature and rates of adverse reactions associated with DTP and DT immunization in infants and children
21. Evaluation of the two-needle strategy for reducing reactions to DTP vaccination
22. The effect of prophylactic acetaminophen administration on reactions to DTP vaccination
23. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy
24. Acteminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus-polio vaccine